Manufacturing Site Equivalency

Achieve greater assurance of supply

Maintaining your supply of cell culture media is key to securing the continued success of your manufacturing process. For this reason, we have been carefully investing in the growth and capabilities of our manufacturing network, while simultaneously achieving equivalency across these sites to increase supply assurance and support your processes.

Contact us

We continue to make significant investments to ensure harmonized core manufacturing sites. This means that processes and quality procedures are equivalent at facilities in Grand Island, NY, USA; Miami, FL, USA; and Paisley, Scotland, allowing us to deliver the same quality products from all sites. Site redundancy and harmonization of equipment, processes, and capabilities are a key strategy in risk mitigation, ultimately helping to prevent delays to your biologic manufacturing processes.

Discover some of the ways we achieve equivalency across our sites:

Our approach to site equivalency

Our facilities are harmonized across four key areas: raw materials, processes, equipment, and finished product testing. This allows us to produce the same standard of cell culture media at each site. We achieve this through:

Explore our equivalency strategies in manufacturing and raw materials